క్లినికల్ ఫార్మకాలజీ & బయోఫార్మాస్యూటిక్స్

నైరూప్య

Clinical Approach of Clostridium Difficile-Associated Diarrhea (CDAD) Treatment by Oral Vancomycin of Isolated Stool Samples of Contaminated Drinking Water in Basrah, Iraq

Muhi N Salman

The aim of this study to trend the clinical treatment of clostridium difficile infected patient by oral vancomycin with lowering of patient risk through control of antibiotic's prescription in hospitals. Clostridium difficile is common cause in inflammation of colon, symptoms of abdominal pain/tenderness diarrhea, fever and colitis. If not carefully managed, it will be possible prognosis to life-threatening cases of mega colon and multi-organ failure. Clinical approach in treatment of C. difficile infection (CDI), was by using (FIRVANQ™) contains vancomycin reconstituted oral glucopeptide preparation of 15g vancomycin, which is given to 20 cases of teenage, were admitted in polyclinic in summer (2019), Basrah governate, IRAQ to treat C. difficile-associated diarrhea outbreak depending on therapeutic oral vancomycin as multiple dose of 40 mg/kg for several days.